Literature DB >> 17599610

Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model.

Gurusher S Panjrath1, Virender Patel, Carolina I Valdiviezo, Navneet Narula, Jagat Narula, Diwakar Jain.   

Abstract

OBJECTIVES: The role of iron toward doxorubicin (DOX) cardiotoxicity was studied using a rodent model of dietary carbonyl iron loading.
BACKGROUND: Doxorubicin, a commonly used anticancer drug, is known to cause serious and potentially life-threatening cardiotoxicity. Doxorubicin cardiotoxicity is thought to be mediated through free-radical injury.
METHODS: Male Sprague Dawley rats fed iron-rich chow (n = 8) and regular chow (n = 8) were treated with DOX or saline (4 animals in each arm). Cardiotoxicity was assessed using mortality, weight changes, Tc-99m annexin-V imaging, histopathology, and immunohistochemistry.
RESULTS: Animals fed iron-rich chow showed significantly higher DOX cardiotoxicity as evidenced by greater weight loss (107 +/- 14 g vs. 55 +/- 10 g weight loss, p < 0.05), higher annexin uptake (0.14 +/- 0.01% vs. 0.08 +/- 0.01% injected dose/g of myocardium, p < 0.05), more severe myocyte injury on electron microscopy, and significantly higher cleaved caspase-3 staining compared with regular chow fed rats given DOX. Feeding iron-rich chow alone did not result in any cardiotoxicity.
CONCLUSIONS: Dietary iron loading resulted in a substantially increased DOX cardiotoxicity in rats. Body iron stores as well as its bioavailability in tissue may be important independent predictors of susceptibility to DOX cardiotoxicity in man. Further clinical studies are warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599610     DOI: 10.1016/j.jacc.2007.02.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

Review 1.  Noninvasive imaging of cardiovascular injury related to the treatment of cancer.

Authors:  Suwat Kongbundansuk; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2014-08

Review 2.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 3.  Genetic Infiltrative Cardiomyopathies.

Authors:  Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

4.  Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.

Authors:  Yoshihiko Ichikawa; Mohsen Ghanefar; Marina Bayeva; Rongxue Wu; Arineh Khechaduri; Sathyamangla V Naga Prasad; R Kannan Mutharasan; Tejaswitha Jairaj Naik; Hossein Ardehali
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

5.  Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.

Authors:  Vinodkumar B Pillai; Samik Bindu; Will Sharp; Yong Hu Fang; Gene Kim; Madhu Gupta; Sadhana Samant; Mahesh P Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-12       Impact factor: 4.733

Review 6.  Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.

Authors:  Diwakar Jain; Tauseef Ahmad; Mitchel Cairo; Wilbert Aronow
Journal:  Ann Transl Med       Date:  2017-09

Review 7.  Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.

Authors:  Diwakar Jain; Raymond R Russell; Ronald G Schwartz; Gurusher S Panjrath; Wilbert Aronow
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 8.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

9.  Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

Authors:  T Simůnek; M Sterba; O Popelová; H Kaiserová; M Adamcová; M Hroch; P Hasková; P Ponka; V Gersl
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

10.  Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in HeLa cells.

Authors:  Emiliano Cocco; Vanessa Porrini; Manuela Derosas; Veronica Nardi; Giorgio Biasiotto; Federica Maccarinelli; Isabella Zanella
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.